# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Flannery O'Connor (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML046-SYN-TD
- Date: 1950-04-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Augusta Pemberton-Diallo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Primary care visit for joint pain and swelling, fevers, fatigue, a facial rash, and protein in the urine in a writer of 25. **S**

## Historical basis

- Mary Flannery O'Connor was born in Savannah, Georgia, on March 25, 1925, the only child of Edward Francis O'Connor and Regina Cline O'Connor. She later dropped her first name for her writing. **D**
- Her father was diagnosed with lupus in 1937; his illness began with a whitish patch of skin on his forehead and arthritis, and was first diagnosed as rheumatoid arthritis. He died of systemic lupus erythematosus in 1941, a month after his 45th birthday, when she was 15. **D**
- O'Connor graduated from Georgia State College for Women in 1945 and then studied at the Writers' Workshop of the State University of Iowa, where she earned a Master of Fine Arts; she was writing her first novel by the late 1940s. **D**
- In December 1949, at 24, she fell seriously ill on a holiday visit to Georgia and spent about a month in hospital, where she had an operation for a floating kidney. **D**

12 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Painful, swollen hands and knees, fevers, tiredness, and a rash on her face, for three months. **S**
- Wants a plain, complete answer about what is wrong, told to her directly, and asks that it not be shared with anyone she has not named. **S**
- Afraid of losing her writing mornings to illness or treatment. **S**

## Strengths and supports

- Strengths: a sharp, ironic sense of humor and a steady religious faith; supports: friends and a writing community; she prefers to keep her health out of conversations about her work **S**

## Medications and allergies

- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for joint pain, no more than 3000 mg a day **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- December 1949: Month-long hospital stay with an operation for a floating kidney **D** (CLM-0004)

## Procedures and immunizations

- No procedures before this visit. **S**
- 1949-10-10: Influenza vaccine, 1949-1950 season **S**
- 1937-10-01: HPV vaccine, 9-valent, series completed (dose 2 of 2) **S**
- 1943-05-14: Tdap vaccine **S**

## Family history

- father: Systemic lupus erythematosus, first diagnosed as rheumatoid arthritis; he died of it in 1941 at 45 **D** (CLM-0002)

## Measurements

Hemoglobin: 11 g/dL (low); White cell count: 3.3 10*3/uL (low); Lymphocytes: 0.8 10*3/uL (low); Platelets: 138 10*3/uL (low); Creatinine: 0.8 mg/dL; eGFR: 101 mL/min/1.73 m²; Potassium: 4.2 mmol/L; Albumin: 3.3 g/dL (low); ALT: 19 U/L; ESR: 52 mm/h (high); CRP: 0.6 mg/dL (high); Urine protein-to-creatinine ratio: 1.6 g/g (high); Urine red cells: 18 /[HPF] (high); PHQ-9: 7; Joint pain (0 to 10): 6. All results are synthetic.

BP 138/86 mmHg; pulse 96 bpm; respirations 16/min; temperature 37.9 °C; oxygen saturation 98% on room air; weight 60 kg; BMI 21.3 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, witty, and direct; asks for exact answers; Mood worn down by fatigue; PHQ-9 7; no thoughts of self-harm. Functional status: Independent; morning stiffness makes buttons and typing hard for the first hour; writing sessions cut short by fatigue. Physical examination is intentionally limited. **S**

## Assessment

1. Pain and swelling of the small joints of both hands, the wrists, and the knees for three months, with an hour of morning stiffness, evening fevers to 38 °C, fatigue, and a red rash over the cheeks and nose after sun; told elsewhere it might be rheumatoid arthritis; cause to be established; status draft. **S**
2. Protein and blood in the urine: protein-to-creatinine ratio 1.6 g/g and 18 red cells per high-power field, with normal creatinine; cause to be established; status draft. **S**

## Plan

- Inflammatory arthritis with fever, rash, cytopenias, and an abnormal urine: blood count, chemistry, ESR and CRP, urine microscopy and protein-to-creatinine ratio today; ANA, anti-dsDNA, anti-Sm, complements, and antiphospholipid antibodies; no NSAIDs with protein in the urine. Guideline: 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 2019;71(9):1400-1412 (2019); 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Rheumatol 2025;77(9):1115-1135 (2024) **S**
- Rheumatology consultation within ten days, to confirm the diagnosis, stage organ involvement, and plan treatment with her. Guideline: EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024;83(1):15-29 (2023) **S**
- Disclosure: every result explained to her directly and in plain words, with a written copy; her health shared only with the people she names. Guideline: EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024;83(1):15-29 (2023) **S**
- Sun protection: broad-spectrum sunscreen SPF 50 or higher, a wide-brimmed hat, and shade in the middle of the day. Guideline: EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024;83(1):15-29 (2023) **S**

## Guideline basis

- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 2019;71(9):1400-1412 (2019), EULAR and American College of Rheumatology
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024;83(1):15-29 (2023), EULAR
- 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Rheumatol 2025;77(9):1115-1135 (2024), American College of Rheumatology
